Last reviewed · How we verify
Intradermal microinjections of tranexamic acid — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Intradermal microinjections of tranexamic acid (Intradermal microinjections of tranexamic acid) — Hayat Abad Medical Complex, Peshawar.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intradermal microinjections of tranexamic acid TARGET | Intradermal microinjections of tranexamic acid | Hayat Abad Medical Complex, Peshawar | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intradermal microinjections of tranexamic acid CI watch — RSS
- Intradermal microinjections of tranexamic acid CI watch — Atom
- Intradermal microinjections of tranexamic acid CI watch — JSON
- Intradermal microinjections of tranexamic acid alone — RSS
Cite this brief
Drug Landscape (2026). Intradermal microinjections of tranexamic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/intradermal-microinjections-of-tranexamic-acid. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab